Sanofi Finalizes Sale of Zentiva to Advent International for EUR1.9 Billion
June 28 2018 - 1:45AM
Dow Jones News
By Alberto Delclaux
Sanofi SA (SAN.FR) said Thursday it had finalized negotiations
to sell its European generics business Zentiva to Advent
International Corp. for 1.9 billion euros ($2.2 billion).
The two companies have signed a share-purchase agreement and the
operation is expected to close in the fourth quarter, subject to
regulatory approvals, Sanofi said.
Write to Alberto Delclaux at alberto.delclaux@dowjones.com
(END) Dow Jones Newswires
June 28, 2018 01:30 ET (05:30 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024
